You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Improving healthcare through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Autoimmune diabetes and related conditions
Where Is the Hemoglobin S?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Estimating GFR: What’s Wrong With Using Serum Creatinine Alone?
1/25/2011 8:15 AM |
Comments (5)
Recommend (1,611)
By
Callum Fraser, PhD
The MDRD (Modification of Diet in Renal Disease) Study equation is widely used to estimate glomerular filtration rate (GFR) and many laboratories report this every time a serum creatinine is requested. However, it has been widely reported that such calculated values underestimate GFR when creatin...(
Read More
)
Posted at 1/25/2011 8:15 AM | Tags:
Management/Medical Informatics
|
Immunology/Infectious Disease
Explosive Growth of Send Out Testing: Can We Curb the Monster?
1/18/2011 9:20 AM |
Comments (6)
Recommend (1,484)
By
Patti Jones, PhD, FACB, and Jason Park, MD
Now days most laboratories are struggling with a new financial sink, the spiraling volume and exponentially spiraling costs of send out testing. A large majority of that growth can be directly attributed to new Molecular Diagnostic tests. In 2009, the molecular diagnostics industry grew 35%. Te...(
Read More
)
Posted at 1/18/2011 9:20 AM | Tags:
Management/Medical Informatics
|
Molecular Pathology and Genetics
High Sensitivity Cardiac Troponin Assays: Benefits and Challenges
1/11/2011 9:14 AM |
Comments (5)
Recommend (1,923)
By
Allan S. Jaffe, MD, FACB
There have been a multiplicity of recent articles in both acute coronary syndromes and heart failure indicating that high sensitivity assays for cardiac troponin provide additional diagnostic and prognostic information but may do so at the cost of specificity for the underlying diagnosis. The pros...(
Read More
)
Posted at 1/11/2011 9:14 AM | Tags:
CVD/Markers/Risk Factors
|
New/Other Disease Markers
Has the Time Come to Bid Adieu to Tests of Fetal Lung Maturity?
1/4/2011 8:01 AM |
Comments (11)
Recommend (2,013)
By
David G. Grenache, PhD, FACB
Abbott Laboratories recently announced that it was ending production of its widely used fetal lung maturity test, the TDx FLM II, due to the retirement of their TDx and TDxFLx instrument platforms. The impact of the loss of this test on the obstetrical and clinical laboratory communities remains...(
Read More
)
Posted at 1/4/2011 8:01 AM | Tags:
Instrumentation/Technology
|
Special Populations
|
New/Other Disease Markers
1 - 4
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093